205 related articles for article (PubMed ID: 31525442)
1. Formulation of injectable glycyrrhizic acid-hydroxycamptothecin micelles as new generation of DNA topoisomerase I inhibitor for enhanced antitumor activity.
Cai J; Luo S; Lv X; Deng Y; Huang H; Zhao B; Zhang Q; Li G
Int J Pharm; 2019 Nov; 571():118693. PubMed ID: 31525442
[TBL] [Abstract][Full Text] [Related]
2. Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery.
Zu Y; Meng L; Zhao X; Ge Y; Yu X; Zhang Y; Deng Y
Int J Nanomedicine; 2013; 8():1207-22. PubMed ID: 23569373
[TBL] [Abstract][Full Text] [Related]
3. A polymeric micelle with an endosomal pH-sensitivity for intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin.
Pu X; Zhao L; Li J; Song R; Wang Y; Yu K; Hou X; Qiao P; Zong L; Chang S
Acta Biomater; 2019 Apr; 88():357-369. PubMed ID: 30822554
[TBL] [Abstract][Full Text] [Related]
4. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N'-octyl chitosan micelles.
Zhu H; Cao J; Cui S; Qian Z; Gu Y
J Pharm Sci; 2013 Apr; 102(4):1318-32. PubMed ID: 23400693
[TBL] [Abstract][Full Text] [Related]
5. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG
Yang L; Hong J; Di J; Guo Y; Han M; Liu M; Wang X
Int J Nanomedicine; 2017; 12():3681-3695. PubMed ID: 28553107
[TBL] [Abstract][Full Text] [Related]
6. Intracellular delivery of 10-hydroxycamptothecin with targeted nanostructured lipid carriers against multidrug resistance.
Liu M; Chen D; Mukerabigwi JF; Chen S; Zhang Y; Lei S; Luo S; Wen Z; Cao Y; Huang X; He H
J Drug Target; 2016; 24(5):433-40. PubMed ID: 26422582
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of hydroxycamptothecin-loaded poly[ethylene glycol]-poly [gamma-benzyl-L-glutamate] micelles against oral squamous cell carcinoma.
Ding XQ; Chen D; Wang AX; Li S; Chen Y; Wang J
Oncol Res; 2007; 16(7):313-23. PubMed ID: 17518269
[TBL] [Abstract][Full Text] [Related]
8. Reduction-sensitive poly(ethylene glycol)-polypeptide conjugate micelles for highly efficient intracellular delivery and enhanced antitumor efficacy of hydroxycamptothecin.
Zong L; Wang Y; Qiao P; Yu K; Hou X; Wang P; Zhang Z; Pang X; Pu X; Yuan Q
Nanotechnology; 2020 Apr; 31(16):165102. PubMed ID: 31899896
[TBL] [Abstract][Full Text] [Related]
9. Hydroxycamptothecin Nanorods Prepared by Fluorescently Labeled Oligoethylene Glycols (OEG) Codendrimer: Antitumor Efficacy in Vitro and in Vivo.
Guo Y; Zhao Y; Wang T; Li R; Han M; Dong Z; Zhu C; Wang X
Bioconjug Chem; 2017 Feb; 28(2):390-399. PubMed ID: 27982573
[TBL] [Abstract][Full Text] [Related]
10. Development and pharmacological evaluation of a PEG based nanoparticulate camptothecin analog for oral administration.
Nekkanti V; Venkateswarlu V; Ansari KA; Pillai R
Curr Drug Deliv; 2011 Nov; 8(6):661-6. PubMed ID: 22313161
[TBL] [Abstract][Full Text] [Related]
11. Intracellular target delivery of 10-hydroxycamptothecin with solid lipid nanoparticles against multidrug resistance.
Liu M; Chen D; Wang C; Chen X; Wen Z; Cao Y; He H
J Drug Target; 2015; 23(9):800-5. PubMed ID: 25766079
[TBL] [Abstract][Full Text] [Related]
12. Berberine-10-hydroxy camptothecine-loaded lipid microsphere for the synergistic treatment of liver cancer by inhibiting topoisomerase and HIF-1α.
Qi Y; Liu G
Drug Deliv; 2021 Dec; 28(1):171-182. PubMed ID: 33427515
[TBL] [Abstract][Full Text] [Related]
13. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y
Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132
[TBL] [Abstract][Full Text] [Related]
14. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles.
Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y
J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683
[TBL] [Abstract][Full Text] [Related]
15. Amphiphilic Hybrid Dendritic-Linear Molecules as Nanocarriers for Shape-Dependent Antitumor Drug Delivery.
Guo Y; Wang T; Zhao S; Han M; Dong Z; Wang X; Wang Y
Mol Pharm; 2018 Jul; 15(7):2665-2673. PubMed ID: 29782803
[TBL] [Abstract][Full Text] [Related]
16. Preparation, Characterization, and in vivo Evaluation of NK4-Conjugated Hydroxycamptothecin-Loaded Liposomes.
Zhou T; Zhang W; Cheng D; Tang X; Feng J; Wu W
Int J Nanomedicine; 2020; 15():2277-2286. PubMed ID: 32280220
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Stability of the Pharmacologically Active Lactone Form of 10-Hydroxycamptothecin by Self-Microemulsifying Drug Delivery Systems.
Li R; Wang Y; Yang Q; Lai B; Zhou X; Feng M
AAPS PharmSciTech; 2020 Nov; 21(8):324. PubMed ID: 33200259
[TBL] [Abstract][Full Text] [Related]
18. Preparation and pharmacodynamics of stearic acid and poly (lactic-co-glycolic acid) grafted chitosan oligosaccharide micelles for 10-hydroxycamptothecin.
Zhou YY; Du YZ; Wang L; Yuan H; Zhou JP; Hu FQ
Int J Pharm; 2010 Jun; 393(1-2):143-51. PubMed ID: 20420886
[TBL] [Abstract][Full Text] [Related]
19. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: in vitro and in vivo evaluation.
Yang X; Liu Y; Zhao Y; Han M; Guo Y; Kuang H; Wang X
Int J Nanomedicine; 2016; 11():2979-94. PubMed ID: 27382284
[TBL] [Abstract][Full Text] [Related]
20. A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting.
Liu Y; Li D; Guo X; Xu H; Li Z; Zhang Y; Song C; Fan R; Tang X; Zhang Z
Int J Nanomedicine; 2017; 12():2227-2242. PubMed ID: 28356739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]